DrChrono’s $20 Million Growth Capital Round


Fenwick & West represented DrChrono Inc. on the deal.

DrChrono Inc. has raised a $20 million growth capital round from ORIX Growth Capital to spur expansion and increase market share through further investing in the technology platform (EHR, medical billing and API) and expansion of engineering, sales, and support functions.

DrChrono will use the funding to spur expansion and increase market share through further investing in the technology platform (EHR, medical billing and API) and expansion of engineering, sales, and support functions.

DrChrono is a company developing the essential platform and services for modern medical practices to make care more informed, more interactive, and more personalized.

ORIX Growth Capital specializes in designing highly customized financing solutions for high-growth companies with investments starting around $5 million and growing to $50 million.

The Fenwick transaction team was led by corporate partner Samuel Angus (Picture).

Involved fees earner: Samuel Angus – Fenwick & West LLP;

Law Firms: Fenwick & West LLP;

Clients: DrChrono;